The lastest cohort analysis. You can see the movement up in hospitalization case rates, but now that we know how many recent cases are breakthroughs and that a lot of hospitalizations in that group are not really for CV-19, and the same is likely true among unvaxed cases, I don’t know how real that is. Also is impacted by testing changes that identify fewer non-case cases. Slight uptick in death rate as well. More of Dave Dixon’s fine work.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
December 2, 2023
Update on One of the Worst Climate Lies
The infamous Mann hockey stick which showed large temperature rises is revealed to be even…
Commentary
November 30, 2023
How Are Family Finances Really Doing?
A detailed look at American family finances suggests that the wealthy are doing great but…
Commentary
November 30, 2023
Is the Economy “Strong”?
While the economy supposedly is cooking along, unsustainable government and consumer spending are the major…